Table 2.

Blood lipid profile at baseline and 12 months of intervention

Variable	Individual intervention (n = 76)	Collective intervention (n = 77)	p-value
Total cholesterol (mmol/L)
Baseline	4.40 (4.20 to 4.60)	4.01 (3.80 to 4.21)	0.015
12 months	4.20 (4.00 to 4.40)	3.92 (3.73 to 4.11)	0.007
p-value†	0.001	0.108
LDL cholesterol (mmol/L)
Baseline	2.58 (2.42 to 2.74)	2.42 (2.21 to 2.62)	0.030
12 months	2.50 (2.32 to 2.68)	2.25 (2.05 to 2.45)	0.012
p-value	0.023	< 0.001
HDL cholesterol (mmol/L)
Baseline	1.29 (1.23 to 1.35)	1.24 (1.18 to 1.30)	0.161
12 months	1.32 (1.26 to 1.38)	1.25 (1.19 to 1.31)	0.142
p-value	0.117	0.413
Triglycerides (mmol/L)
Baseline	1.19 (1.07 to 1.31)	1.10 (0.97 to 1.23)	0.126
12 months	0.90 (0.82 to 0.98)	0.95 (0.86 to 1.04)	0.548
p-value	< 0.001	0.021
Apo A1 (g/L)
Baseline	1.33 (1.28 to 1.38)	1.37 (1.29 to 1.45)	0.663
12 months	1.33 (1.28 to 1.38)	1.35 (1.31 to 1.39)	0.310
p-value	0.978	0.193
Apo B (g/L)
Baseline	0.76 (0.71 to 0.81)	0.76 (0.70 to 0.82)	0.496
12 months	0.75 (0.70 to 0.80)	0.73 (0.68 to 0.78)	0.269
p-value	0.892	0.322
AIP
Baseline	0.29 (0.23 to 0.35)	0.27 (0.21 to 0.33)	0.463
12 months	0.17 (0.12 to 0 to 22)	0.22 (0.17 to 0.27)	0.230
p-value†	< 0.001	0.100

Values are mean (95% CI)

LDL low to density to lipoprotein, HDL high to density to lipoprotein; Apo A1 apolipoprotein A1, Apo B apolipoprotein B, AIP atherogenic index of plasma